| 000 | 01118 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517145244.0 | ||
| 264 | 0 | _c20170906 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1530-6860 | ||
| 024 | 7 |
_a10.1096/fj.201700028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScolnick, Edward M | |
| 245 | 0 | 0 |
_aThe Path to New Therapies for Schizophrenia and Bipolar Illness. _h[electronic resource] |
| 260 |
_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _c04 2017 |
||
| 300 |
_a1254-1259 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenome, Human |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 773 | 0 |
_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 31 _gno. 4 _gp. 1254-1259 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1096/fj.201700028 _zAvailable from publisher's website |
| 999 |
_c27033046 _d27033046 |
||